American Health Packaging FDA Record
- Latest inspection VAI · Jun 15, 2026
- 2 Class I recalls
- No warning letters matched by name
American Health Packaging has 61 FDA recalls (2 Class I), 8 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "American Health Packaging" is on file.
- Latest recall
- D-0042-2027 · Class II · Oct 6, 2026
- Latest inspection
- Jun 15, 2026 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 61 (2 Class I) | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 8 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
American Health Packaging: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 2 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 3 | 0 |
| 2021 | 0 | 0 | 0 | 5 | 0 |
| 2020 | 0 | 0 | 0 | 4 | 0 |
| 2019 | 0 | 0 | 0 | 15 | 0 |
| 2018 | 0 | 0 | 0 | 4 | 0 |
| 2017 | 2 | 0 | 0 | 0 | 0 |
Reviewing American Health Packaging as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check American Health Packaging yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0042-2027 | Class II | Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health… | Oct 6, 2026 |
| D-0840-2026 | Class III | Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American… | Aug 19, 2026 |
| D-0880-2022 | Class III | Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules (10 x 10), 10-count… | May 3, 2022 |
| D-0790-2022 | Class III | Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1… | Apr 12, 2022 |
| D-0652-2022 | Class II | Oxycodone Hydrochloride Oral Solution, USP (C-II), 5 mg/5 mL, Delivers 5 mL per Cup, 1 Tray of 10… | Feb 22, 2022 |
| D-0451-2022 | Class II | Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only, Manufactured… | Dec 20, 2021 |
| D-0020-2022 | Class II | GlipiZIDE Extended-Release Tablets, 2.5 mg, 30 Tablets (3 blister cards each with 10 individually… | Sep 17, 2021 |
| D-0854-2021 | Class II | Valproic Acid Oral Solution, USP, 500 mg/10 mL, 100 10 mL unit dose cups per case, Rx Only, Packaged… | Sep 15, 2021 |
| D-0813-2021 | Class III | Sirolimus Tablets 1 mg, 30 Tablets (5 blister cards x 6 unit doses), Rx only, Packaged and… | May 12, 2021 |
| D-0232-2021 | Class II | Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, 100 per carton (10 capsules x 10… | Jan 7, 2021 |
| D-1372-2020 | Class III | Nabumetone Tablets, USP, 500 mg, 100 Tablets per carton (10 tablets x 10 blister cards), Rx only… | Jun 10, 2020 |
| D-1293-2020 | Class II | Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10), Rx only, Distributed by… | May 19, 2020 |
| D-0849-2020 | Class II | Desmopressin Acetate Tablets, 0.2 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged… | Feb 7, 2020 |
| D-0848-2020 | Class II | Desmopressin Acetate Tablets, 0.1 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged… | Feb 7, 2020 |
| D-0854-2020 | Class II | Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Packaged… | Dec 4, 2019 |
| D-1003-2020 | Class II | Ranitidine Tablets, USP, 150 mg, 100 Tablets (10 tablets x 10 blister card), Rx Only, Packaged and… | Nov 20, 2019 |
| D-0631-2020 | Class II | Ranitidine Syrup (Ranitidine Oral Solution USP), 15 mg/mL, 150 mg/10 mL per cup, Rx Only… | Nov 1, 2019 |
| D-1847-2019 | Class III | Lamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21… | Aug 27, 2019 |
| D-1821-2019 | Class II | Carbamazepine, Extended-Release Tablets, USP, 400 mg, 30 Tablets (3 blister cards x 10 unit doses)… | Aug 9, 2019 |
| D-1432-2019 | Class II | Pramipexole Dihydrochloride Tablets, 0.25 mg, 100 Tablets (10 x 10), Rx Only, Packaged and… | May 13, 2019 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jun 15, 2026 | Columbus, OH | Drugs | Voluntary Action Indicated (VAI) | 3000209995 |
| May 27, 2022 | Columbus, OH | Drugs | No Action Indicated (NAI) | 3000209995 |
| Aug 16, 2017 | Columbus, OH | Drugs | No Action Indicated (NAI) | 3000209995 |
| Jun 15, 2017 | Columbus, OH | Drugs | Voluntary Action Indicated (VAI) | 3000209995 |
| Jul 30, 2015 | Columbus, OH | Drugs | No Action Indicated (NAI) | 3000209995 |
| Jun 10, 2013 | Columbus, OH | Drugs | No Action Indicated (NAI) | 3000209995 |
| Sep 10, 2012 | Columbus, OH | Drugs | Voluntary Action Indicated (VAI) | 3000209995 |
| Jul 16, 2010 | Columbus, OH | Drugs | Voluntary Action Indicated (VAI) | 3000209995 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3000209995 | Columbus, OH | 8 | Jun 15, 2026 |
American Health Packaging and the FDA: common questions
Has American Health Packaging received an FDA warning letter?
No FDA warning letter addressed to the name "American Health Packaging" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has American Health Packaging received an FDA Form 483?
FDA has not published a Form 483 for "American Health Packaging" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect American Health Packaging?
The most recent FDA inspection on file ended Jun 15, 2026 at Columbus, OH and was classified VAI. FDA has 8 inspections of American Health Packaging on file.
Has American Health Packaging had an FDA recall?
Yes. American Health Packaging has 61 FDA recalls on record, 2 of them Class I, the most serious class. The most recent started Oct 6, 2026.
Need more than this page shows? Ask about American Health Packaging in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.